<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A retrospective analysis was performed of 238 patients, aged 12 years and older, with non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> presenting to the <z:hpo ids='HP_0000001'>All</z:hpo> India Institute of Medical Sciences, New Delhi, India, between September 1975 and December 1982 </plain></SENT>
<SENT sid="1" pm="."><plain>Pathologic material was reviewed and classified according to the modified Rappaport classification </plain></SENT>
<SENT sid="2" pm="."><plain>The most common histologic type encountered was diffuse histiocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (39%), followed by diffuse poorly differentiated lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (29%), and diffuse mixed histiocytic and lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (9%) </plain></SENT>
<SENT sid="3" pm="."><plain>Nodular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> constituted 9% of <z:hpo ids='HP_0000001'>all</z:hpo> non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>A lower frequency of nodular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, a lower median <z:hpo ids='HP_0011007'>age of onset</z:hpo> (45 years), and a higher male to female ratio (4.5:1) as compared with Western countries was observed </plain></SENT>
<SENT sid="5" pm="."><plain>Survival information on 90 patients revealed no effect of age, sex, stage of disease, and "B" symptoms on survival, whereas histologic diagnosis had a significant influence on survival (P less than 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>A median survival of 24 months in 58 patients receiving chemotherapy is comparable to that reported by other investigators </plain></SENT>
</text></document>